Cargando…

Opioid use disorder in two samples of the Lebanese population: scale validation and correlation with sleep and mood disorders

BACKGROUND: The revised Opioid Risk Tool (ORT-OUD) is a brief, self-report scale designed to provide clinicians with a simple, validated method to screen for the risk of developing an Opioid Use Disorder (OUD) in patients without a prior history of substance abuse. This study aimed to translate and...

Descripción completa

Detalles Bibliográficos
Autores principales: Chamoun, Karam, Mouawad, Joseph, Salameh, Pascale, Sacre, Hala, Haddad, Ramzi, Khabbaz, Lydia Rabbaa, Megarbane, Bruno, Hajj, Aline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619223/
https://www.ncbi.nlm.nih.gov/pubmed/37914993
http://dx.doi.org/10.1186/s12888-023-05304-8
_version_ 1785129940119715840
author Chamoun, Karam
Mouawad, Joseph
Salameh, Pascale
Sacre, Hala
Haddad, Ramzi
Khabbaz, Lydia Rabbaa
Megarbane, Bruno
Hajj, Aline
author_facet Chamoun, Karam
Mouawad, Joseph
Salameh, Pascale
Sacre, Hala
Haddad, Ramzi
Khabbaz, Lydia Rabbaa
Megarbane, Bruno
Hajj, Aline
author_sort Chamoun, Karam
collection PubMed
description BACKGROUND: The revised Opioid Risk Tool (ORT-OUD) is a brief, self-report scale designed to provide clinicians with a simple, validated method to screen for the risk of developing an Opioid Use Disorder (OUD) in patients without a prior history of substance abuse. This study aimed to translate and validate the Arabic version of ORT-OUD in the Lebanese population and assess its clinical validity in a sample of patients with OUD. METHODS: This cross-sectional study in the Lebanese population used several validated scales to assess the risk of OUD, including the Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST). Other tools evaluated chronotype and sleep and mood disturbances. Principal component analysis with Varimax rotation was applied to assess ORT-OUD construct validity. Convergent validity with the Arabic version of ASSIST was evaluated. The ORT-OUD criterion validity was then assessed in a clinical sample of patients with OUD. RESULTS: This study included 581 participants. The prevalence of the OUD risk in the Lebanese population using the ORT-OUD scale and the ASSIST-opioids scale was estimated at 14.5% and 6.54%, respectively. No items of the ORT-OUD were removed; all items converged over a solution of four factors with an eigenvalue > 1, explaining a total of 68.2% of the variance (Cronbach’s alpha = 0.648). The correlation coefficients between the ORT-OUD total score and ASSIST subscales were as follows: ASSIST-opioids (r = 0.174; p = < 0.001), ASSIST-sedatives (r = 0.249; p < 0.001), and ASSIST-alcohol (r = 0.161; p = < 0.001). ORT-OUD clinical validation showed a correlation with ASSIST-opioids (r = 0.251; p = 0.093) and ASSIST-sedatives (r = 0.598; p < 0.001). Higher ORT-OUD scores were associated with a family and personal history of alcohol and substance consumption and higher insomnia and anxiety scores. CONCLUSIONS: This study is the first to validate the Arabic version of ORT-OUD in the Lebanese population, an essential step towards improving the detection and management of OUD in this population. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12888-023-05304-8.
format Online
Article
Text
id pubmed-10619223
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106192232023-11-02 Opioid use disorder in two samples of the Lebanese population: scale validation and correlation with sleep and mood disorders Chamoun, Karam Mouawad, Joseph Salameh, Pascale Sacre, Hala Haddad, Ramzi Khabbaz, Lydia Rabbaa Megarbane, Bruno Hajj, Aline BMC Psychiatry Research BACKGROUND: The revised Opioid Risk Tool (ORT-OUD) is a brief, self-report scale designed to provide clinicians with a simple, validated method to screen for the risk of developing an Opioid Use Disorder (OUD) in patients without a prior history of substance abuse. This study aimed to translate and validate the Arabic version of ORT-OUD in the Lebanese population and assess its clinical validity in a sample of patients with OUD. METHODS: This cross-sectional study in the Lebanese population used several validated scales to assess the risk of OUD, including the Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST). Other tools evaluated chronotype and sleep and mood disturbances. Principal component analysis with Varimax rotation was applied to assess ORT-OUD construct validity. Convergent validity with the Arabic version of ASSIST was evaluated. The ORT-OUD criterion validity was then assessed in a clinical sample of patients with OUD. RESULTS: This study included 581 participants. The prevalence of the OUD risk in the Lebanese population using the ORT-OUD scale and the ASSIST-opioids scale was estimated at 14.5% and 6.54%, respectively. No items of the ORT-OUD were removed; all items converged over a solution of four factors with an eigenvalue > 1, explaining a total of 68.2% of the variance (Cronbach’s alpha = 0.648). The correlation coefficients between the ORT-OUD total score and ASSIST subscales were as follows: ASSIST-opioids (r = 0.174; p = < 0.001), ASSIST-sedatives (r = 0.249; p < 0.001), and ASSIST-alcohol (r = 0.161; p = < 0.001). ORT-OUD clinical validation showed a correlation with ASSIST-opioids (r = 0.251; p = 0.093) and ASSIST-sedatives (r = 0.598; p < 0.001). Higher ORT-OUD scores were associated with a family and personal history of alcohol and substance consumption and higher insomnia and anxiety scores. CONCLUSIONS: This study is the first to validate the Arabic version of ORT-OUD in the Lebanese population, an essential step towards improving the detection and management of OUD in this population. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12888-023-05304-8. BioMed Central 2023-11-01 /pmc/articles/PMC10619223/ /pubmed/37914993 http://dx.doi.org/10.1186/s12888-023-05304-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Chamoun, Karam
Mouawad, Joseph
Salameh, Pascale
Sacre, Hala
Haddad, Ramzi
Khabbaz, Lydia Rabbaa
Megarbane, Bruno
Hajj, Aline
Opioid use disorder in two samples of the Lebanese population: scale validation and correlation with sleep and mood disorders
title Opioid use disorder in two samples of the Lebanese population: scale validation and correlation with sleep and mood disorders
title_full Opioid use disorder in two samples of the Lebanese population: scale validation and correlation with sleep and mood disorders
title_fullStr Opioid use disorder in two samples of the Lebanese population: scale validation and correlation with sleep and mood disorders
title_full_unstemmed Opioid use disorder in two samples of the Lebanese population: scale validation and correlation with sleep and mood disorders
title_short Opioid use disorder in two samples of the Lebanese population: scale validation and correlation with sleep and mood disorders
title_sort opioid use disorder in two samples of the lebanese population: scale validation and correlation with sleep and mood disorders
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619223/
https://www.ncbi.nlm.nih.gov/pubmed/37914993
http://dx.doi.org/10.1186/s12888-023-05304-8
work_keys_str_mv AT chamounkaram opioidusedisorderintwosamplesofthelebanesepopulationscalevalidationandcorrelationwithsleepandmooddisorders
AT mouawadjoseph opioidusedisorderintwosamplesofthelebanesepopulationscalevalidationandcorrelationwithsleepandmooddisorders
AT salamehpascale opioidusedisorderintwosamplesofthelebanesepopulationscalevalidationandcorrelationwithsleepandmooddisorders
AT sacrehala opioidusedisorderintwosamplesofthelebanesepopulationscalevalidationandcorrelationwithsleepandmooddisorders
AT haddadramzi opioidusedisorderintwosamplesofthelebanesepopulationscalevalidationandcorrelationwithsleepandmooddisorders
AT khabbazlydiarabbaa opioidusedisorderintwosamplesofthelebanesepopulationscalevalidationandcorrelationwithsleepandmooddisorders
AT megarbanebruno opioidusedisorderintwosamplesofthelebanesepopulationscalevalidationandcorrelationwithsleepandmooddisorders
AT hajjaline opioidusedisorderintwosamplesofthelebanesepopulationscalevalidationandcorrelationwithsleepandmooddisorders